Sun Pharma is expected to report modest Q2 FY26 earnings growth, with PAT likely up 2% YoY and revenue rising 7%. Analysts cite Leqselvi launch costs, weak Taro performance, and high R&D spend as margin drags, even as domestic and specialty segments continue to drive overall growth.Read More
Groww launches its IPO today, aiming to raise Rs 6,632 crore. The investment platform, a market leader in India, faces regulatory challenges, particularly concerning futures and options trading, which has historically driven its growth. Despite these headwinds, Groww is diversifying its offerings to ensure continued expansion.Read More
The US economy is surprisingly strong, with significant corporate spending projected. In contrast, global investors are cautious about India, underweighting its market due to an earnings slowdown. However, a turnaround is anticipated with expected rate cuts, GST reductions, and PSU pay hikes. Improved corporate earnings are seen as the key to attracting foreign investment back to India.Read More
India Inc’s Q2 FY26 earnings are outperforming expectations, led by oil & gas, capital goods, and technology sectors. Motilal Oswal notes modest Nifty EPS upgrades as midcaps continue to outperform largecaps, margins expand 170 bps YoY, and the earnings cycle shows signs of bottoming out for sustained growth.Read More
Billionbrains Garage Ventures (Groww) raised Rs 2,984 crore in its Rs 6,632 crore IPO anchor round, drawing top domestic MFs, global sovereign funds, and tech investors like GIC, ADIA, and SCGE.Read More
Nulla vitae elit libero, a pharetra augue. Nulla vitae elit libero, a pharetra augue. Nulla vitae elit libero, a pharetra augue. Donec sed odio dui. Etiam porta sem malesuada.
